Collegium Pharmaceutical (COLL) Change in Account Payables (2014 - 2026)

Collegium Pharmaceutical's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 127.49% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$11.0 million (down 313.02% YoY), while the FY2025 annual figure was $6.7 million, up 159.57% from the prior year.
• Change in Account Payables was -$3.8 million for Q1 2026 at Collegium Pharmaceutical, down from $3.0 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $13.9 million in Q1 2025 to a low of -$7.0 million in Q2 2025.
• Historically, Change in Account Payables has averaged -$237235.3 across 5 years, with a median of -$502000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Account Payables slumped 603.3% in 2024, then soared 648.86% in 2025.
• A 5-year view of Change in Account Payables shows it stood at -$4.1 million in 2022, then jumped by 219.6% to $5.0 million in 2023, then plunged by 83.65% to $810000.0 in 2024, then surged by 275.93% to $3.0 million in 2025, then sank by 225.68% to -$3.8 million in 2026.
• The last three Change in Account Payables figures came in at -$3.8 million (Q1 2026), $3.0 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.